BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
1-Year Return
36.47%
This Quarter Return
-3.41%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$800M
AUM Growth
-$94.7M
(-11%)
Cap. Flow
-$30M
Cap. Flow
% of AUM
-3.75%
Top 10 Holdings %
Top 10 Hldgs %
66.9%
Holding
36
New
3
Increased
1
Reduced
4
Closed
2
Top Buys
| 1 |
Disc Medicine
IRON
|
+$42.2M |
| 2 |
Aclaris Therapeutics
ACRS
|
+$27.5M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
+$21.8M |
| 4 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$3.89M |
Top Sells
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$45M |
| 2 |
Natera
NTRA
|
+$38.9M |
| 3 |
Protagonist Therapeutics
PTGX
|
+$25.8M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
+$11.2M |
| 5 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
+$2.41M |
Sector Composition
| 1 | Healthcare | 98.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tango Therapeutics
TNGX
$727M
| $7.59M | 0.95% |
1,921,790
| – | – |
|
|
SYRS
27
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $5.67M | 0.71% |
2,124,694
| – | – |
|
28
Nautilus Biotechnolgy
NAUT
$91M
| $5.54M | 0.69% |
2,000,000
| – | – |
|
29
C4 Therapeutics
CCCC
$189M
| $5.16M | 0.64% |
1,642,210
| – | – |
|
|
THRD
30
DELISTED
Third Harmonic Bio
THRD
| $2.64M | 0.33% |
640,631
-511,026
| -44% | -$2.11M |
|
31
Invivyd
IVVD
$299M
| $2.33M | 0.29% |
1,937,207
| – | – |
|
32
Spyre Therapeutics
SYRE
$945M
| $1.55M | 0.19% |
213,908
| – | – |
|
|
APTX
33
DELISTED
Aptinyx Inc. Common Stock
APTX
| $1.11M | 0.14% |
8,891,758
| – | – |
|
34
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$62.3M
| $184K | 0.02% |
100,000
| – | – |
|
|
35
Acadia Pharmaceuticals
ACAD
$3.98B
| – | – |
-701,402
| Closed | -$11.2M |
|
|
36
Protagonist Therapeutics
PTGX
$3.66B
| – | – |
-2,364,410
| Closed | -$25.8M |
|